TP53 and ovarian neoplasm: The presence of shorter p53 isoforms was found to be associated with chemoresistance in an early study of ovarian tumor resistance, and it was found that the presence of p53 aggregates affects the response of ovarian tumors to chemotherapy [72, 73], strongly suggesting a more robust relationship between p53 isoforms and aggregation.